Its molecular formula is C 26 H 37 N 5 O 2, and its molecular weight is 451
Common side effects of cabergoline include nausea, constipation, headache, and dizziness
Interestingly, cabergoline treatment for 24 hours inhibited the increase of glutamate concentration caused by H 2 O 2 (20 min) (Fig
The dopamine agonist cabergoline has been used to treat prolactinomas, Parkinson’s disease, Cushing’s disease, and sexual
Biochemical control with cabergoline alone was achieved in approximately one-third of acromegaly patients according to a meta-analysis
Cabergoline Cabergoline and lisuride are non-selective agonists at dopaminergic receptors and are also agonists at serotonergic receptors Millan et al (2002), Newman-Tancredi et
Cabergoline is a long-acting agonist of dopamine, which has a high affinity to dopamine receptors (type 2)
Cabergoline is a specific dopamine D2 receptor agonist developed to treat Parkinson's disease and hyperprolactinemia and is reported to exert promising anti-inflammatory
Generic name: cabergoline [ ca-BER-goe-leen ] Brand name: Dostinex
Aims To determine whether